Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 29.92
-0.04 (-0.13%)
Sep 23, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 4.7 billion as of September 23, 2026. Its market cap has decreased by -48.49% in one year.
Market Cap
4.70B
Enterprise Value
4.45B
Revenue
917.05M
Ranking
n/a
PE Ratio
28.01
Stock Price
29.92
ChartMarket Cap Chart
Since August 27, 2018, SHA:603590's market cap has decreased from 5.61B to 4.70B, a decrease of -16.12%. That is a compound annual growth rate of -2.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.70B | -25.68% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ChemPartner PharmaTech | 5.04B |
| Kexing Biopharm | 5.00B |
| Shanghai Obio Technology (Group) Corp. | 4.94B |
| Shenzhen Weiguang Biological Products | 4.91B |
| Anhui Huaheng Biotechnology | 4.63B |
| Zhejiang Wecome Pharmaceutical Company | 4.41B |
| Wuhan Hvsen Biotechnology | 4.35B |
| Xiangxue Pharmaceutical | 4.34B |